Finance

Beta
Lists
214370:KOSDAQ
Caregen Co Ltd
â‚©68,900.00
-4.17%
(-3,000.00) 1D
Jun 25, 3:30:06 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 214370...
Open
â‚©70,000
High
â‚©72,800
Low
â‚©66,100
Mkt. cap
3.70T
Avg. vol.
106.93K
Volume
80.40K
Dividend
0.63%
Quarterly dividend
â‚©109
Ex-dividend date
Dec 29, 2025
P/E ratio
144.12
52-wk high
â‚©153,800
52-wk low
â‚©31,300
EPS
â‚©478
Shares outstanding
53.72M
No. of employees
193
Open
â‚©70,000
High
â‚©72,800
Low
â‚©66,100
Mkt. cap
3.70T
Avg. vol.
106.93K
Volume
80.40K
Dividend
0.63%
Quarterly dividend
â‚©109
Ex-dividend date
Dec 29, 2025
P/E ratio
144.12
52-wk high
â‚©153,800
52-wk low
â‚©31,300
EPS
â‚©478
Shares outstanding
53.72M
No. of employees
193
News stories
From sources across the web
About Caregen Co Ltd
CEO-
Employees193
Founded2001
Headquarters-
SectorPharmaceutical industry
Websitecaregen.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
18.12B
17.09B
16.31B
22.70B
Cost of goods sold
5.53B
2.49B
5.92B
7.34B
Cost of revenue
5.53B
2.49B
5.92B
7.34B
Research and development expenses
1.71B
1.39B
1.45B
1.03B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.90B
2.56B
3.17B
3.57B
Operating expense
5.14B
4.74B
17.46B
5.15B
Total operating expenses
10.68B
7.22B
23.38B
12.49B
Operating income
7.44B
9.87B
-7.07B
10.21B
Other non operating income
60.75M
58.90M
148.74M
43.16M
EBT including unusual items
4.21B
12.43B
-4.89B
13.06B
EBT excluding unusual items
4.11B
11.64B
-5.71B
12.92B
Income tax expense
-583.52M
2.27B
-1.60B
1.36B
Effective tax rate
-13.86%
18.29%
32.83%
10.44%
Other operating expenses
12.12M
250.76M
177.70M
29.79M
Net income
4.79B
10.16B
-3.28B
11.69B
Net profit margin
26.46%
59.43%
-20.12%
51.51%
Earnings per share
-
-
-
-
Interest and investment income
113.22M
91.63M
63.60M
46.67M
Interest expense
-
-
-
-
Net interest expenses
113.22M
91.63M
63.60M
46.67M
Depreciation and amortization charges
294.51M
296.45M
446.50M
270.70M
EBITDA
8.65B
11.09B
-5.70B
11.44B
Gain or loss from assets sale
-
939.00K
910.00K
-1.18M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer